This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Lexicon Pharmaceuticals Inc (LXRX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 37.50M 30.42M 186.31M 47.21M
Receivables 790.00K 1.38M 350.00K 744.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 134.55M 230.94M 285.79M 214.74M
Property, Plant & Equipment, Gross 123.31M 126.05M 126.95M 133.75M
Accumulated Depreciation & Depletion 81.94M 83.42M 80.54M 80.32M
Property, Plant & Equipment, Net 41.36M 42.63M 46.42M 53.43M
Intangibles 53.56M 53.56M 53.56M 53.56M
Other Non-Current Assets 144.00K 109.00K 205.00K 619.00K
Total Non-Current Assets 139.61M 140.84M 144.72M 152.15M
Liabilities & Shareholder Equity
Total Assets 274.16M 371.78M 430.51M 366.88M
Accounts Payable 9.72M 7.66M 6.04M 3.16M
Short Term Debt 1.71M 1.57M 1.44M 1.14M
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 19.29M 18.28M 21.39M 10.78M
Long Term Debt 20.17M 21.88M 23.45M 27.34M
Deferred Income Taxes 18.74M 18.74M 18.74M 18.74M
Other Non-Current Liabilities 45.79M 46.19M 69.36M 63.00M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 84.70M 86.82M 111.55M 109.08M
Total Liabilities 104.00M 105.10M 132.94M 119.86M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 170.16M 266.68M 297.57M 247.02M
Common Par 514.00K 512.00K 480.00K 338.00K
Additional Paid In Capital 1.18B 1.17B 1.09B 920.32M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.00B -899.83M -789.62M -673.41M
Treasury Stock -1.50M -630.00K -345.00K -237.00K
Other Equity Adjustments 2.00K 23.00K 21.00K 5.00K
Total Capitalization 190.33M 288.56M 321.02M 274.37M
Total Equity 170.16M 266.68M 297.57M 247.02M
Total Liabilities & Stock Equity 274.16M 371.78M 430.51M 366.88M
Total Common Shares Outstanding 513.54M 512.38M 480.17M 337.41M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 814.00K 380.00K 218.00K 158.00K
Basic Weighted Shares Outstanding 513.12M 489.71M 340.76M 302.84M
Diluted Weighted Shares Outstanding 513.12M 489.71M 340.76M 302.84M
Number of Employees 149 230 225 290
Number of Part-Time Employees 0 0 0 0
LXRX News

LXRX Lexicon Pharmaceuticals Inc

Analysts Ratings for LXRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 5
Moderate Buy 0 0 0 0
Hold 1 1 1 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 1
GET LXRX ANALYST REPORT

Brokerage Partners

LXRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs